{
  "ptid_time": "032_S_1169_2012-02-02",
  "img_path": "/data/qiuhui/data/adni/images/032_S_1169/2012-02-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 26,552 mm³, 5.4% below the reference mean. With a Z-score of -0.12 (45.1th percentile), this represents normal volume ; hippocampal volume measures 5,436 mm³, 23.6% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; whole brain volume measures 946,957 mm³, 2.8% below the reference mean. With a Z-score of -0.36 (36.0th percentile), this represents normal volume ; entorhinal cortex volume measures 2,072 mm³, 43.6% below the reference mean. With a Z-score of -2.68 (0.4th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,882 mm³, 12.5% below the reference mean. With a Z-score of -1.14 (12.7th percentile), this represents mild atrophy; middle temporal gyrus volume measures 19,892 mm³, 3.8% above the reference mean. With a Z-score of 0.33 (62.8th percentile), this represents normal volume . ",
  "text_data": "Age is 77.2 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Alcohol Abuse; Smoking. MMSE: 30.0. MoCA: 25.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.00 SUVR (normal ); Total tau: 372.20 pg/mL (moderate elevated); Phosphorylated tau: 34.48 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease, along with mild atrophy in the fusiform gyrus. Despite normal cognitive scores (MMSE 30, MoCA 25), the structural changes and moderately elevated tau biomarkers (T-tau, P-tau) suggest early neurodegenerative pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal/entorhinal atrophy).  \n\n**Confidence:** **Medium** (cognitive scores are normal, but biomarker and structural changes are concerning; APOE4-negative status and normal AV45 (amyloid PET) introduce some uncertainty).  \n\n*Note:* If amyloid positivity (AV45) were confirmed, the diagnosis would lean more strongly toward **prodromal Alzheimer’s disease (MCI due to AD)**. Current data suggests non-AD pathology (e.g., primary tauopathy) is also possible.",
  "timestamp": "2025-07-26T05:00:51.612012"
}